Anna-Maria Costa
Overview
Explore the profile of Anna-Maria Costa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olaimat A, Jafarzadehbalagafsheh P, Gol M, Costa A, Biagini G, Lucchi C
Animals (Basel)
. 2025 Feb;
15(3).
PMID: 39943185
Trilostane is a drug able to block the synthesis of progesterone from pregnenolone, dependent on the enzyme 3β-hydroxysteroid dehydrogenase/Δ isomerase. As a consequence of this effect, it is used to...
2.
Lucchi C, Marcucci M, Aledresi K, Costa A, Cannazza G, Biagini G
Pharmaceuticals (Basel)
. 2024 Sep;
17(9).
PMID: 39338349
Refractoriness to antiseizure medications is still a major concern in the pharmacotherapy of epilepsy. For this reason, we decided to evaluate the combination of levetiracetam and cannabidiol, administered at a...
3.
Jacobson J, Fabri L, Osowicki J, Shanthikumar S, Costa A, Ortika B, et al.
PLoS One
. 2024 Jun;
19(6):e0304861.
PMID: 38917227
Pleural empyema is a serious complication of pneumonia in children. Negative bacterial cultures commonly impede optimal antibiotic therapy. To improve bacterial identification, we developed a molecular assay and evaluated its...
4.
Balgovind P, Atchison S, Danielewski J, Garland S, Costa A, Bodiyabadu K, et al.
Lett Appl Microbiol
. 2023 Oct;
76(11).
PMID: 37881107
The LightMix® Modular Mycoplasma Macrolide and LightMix® Modular parC Fluoroquinolone Resistance assays (TIB Molbiol) were evaluated using sequential Mycoplasma genitalium positive (n = 125) and negative (n = 93) clinical...
5.
Dong X, Deng Y, Aziz A, Whitney P, Clark J, Harris P, et al.
J Clin Virol
. 2023 Mar;
161:105423.
PMID: 36934591
Background: Human Respiratory Syncytial Virus (RSV) infections pose a significant risk to human health worldwide, especially for young children. Whole genome sequencing (WGS) provides a useful tool for global surveillance...
6.
Tesiye M, Gol M, Fadardi M, Kani S, Costa A, Ghasemi-Kasman M, et al.
Cells
. 2022 Dec;
11(24).
PMID: 36552892
Epilepsy is a life-threatening neurological disease that affects approximately 70 million people worldwide. Although the vast majority of patients may be successfully managed with currently used antiseizure medication (ASM), the...
7.
Senn L, Costa A, Avallone R, Socala K, Wlaz P, Biagini G
Pharmacol Ther
. 2022 Nov;
241:108316.
PMID: 36436690
The peroxisome proliferator-activated receptor gamma (PPARγ), which belongs to the family of nuclear receptors, has been mainly studied as an important factor in metabolic disorders. However, in recent years the...
8.
Costa A, Russo F, Senn L, Ibatici D, Cannazza G, Biagini G
Pharmaceuticals (Basel)
. 2022 May;
15(5).
PMID: 35631322
We evaluated the effects of cannabidiol (CBD) on seizures and peroxisome proliferator-activated receptor gamma (PPARγ) levels in an animal model of temporal lobe epilepsy (TLE). Adult male Sprague-Dawley rats were...
9.
Costa A, Lo Barco T, Spezia E, Conti V, Roli L, Marini L, et al.
J Pers Med
. 2022 Apr;
12(4).
PMID: 35455643
Children with epilepsy and identified as responders to antiseizure medications (ASMs) were found to present markedly higher ghrelin plasma levels when compared to drug-resistant patients. However, it was undetermined if...
10.
Costa A, Senn L, Anceschi L, Brighenti V, Pellati F, Biagini G
Pharmaceuticals (Basel)
. 2021 Dec;
14(12).
PMID: 34959660
Compounds present in L. preparations have recently attracted much attention in the treatment of drug-resistant epilepsy. Here, we screened two olive oil extracts from a non-psychoactive variety, fully characterized by...